PHARMAC have announced CGM funding for people with Type 1 diabetes from 1 October 2024.
Learn more - Pharmac announcement
Menu
X
If you know the product code enter it here
GDS-NT0100
Peripheral neuropathy cannot be excluded without regular foot screening in conjunction with symptomatic and clinical assessments. Neuropen® is an effective aid to this screening programme, meeting and exceeding current practices by being the first dual-purpose, pocket-sized device designed to provide a safe and reliable test. PLEASE NOTE: All the prices are EXCLUDING GST AND SHIPPING, this will be added at the checkout stage.
Brand: Owen Mumford
Go to checkout
